اکثر مکاتبات کومش از طریق ایمیل سایت می باشد. لطفا Spam ایمیل خود را نیز چک نمایید.
   [Home ] [Archive]   [ فارسی ]  
:: ::
Main Menu
Home::
Journal Information::
Articles archive::
For Authors::
Subscription::
Contact us::
Site Facilities::
Webmail::
Editorial Board::
::
Search in website

Advanced Search
..
Receive site information
Enter your Email in the following box to receive the site news and information.
..
:: Volume 25, Issue 5 (Sep and Oct 2023 2023) ::
Koomesh 2023, 25(5): 12-12 Back to browse issues page
The Effect of Melatonin in Diffuse Axonal Injury: A Clinical Trial
Nazanin Sabet , Alireza Ghaed amini , Saeed Karamouzian , Mohammad Khaksari , Zahra Soltani
Abstract:   (256 Views)
Introduction: Neuroprotective effect of melatonin in traumatic brain injury (TBI) has been shown in many animal studies. This clinical trial was designed to investigate the effect of melatonin on neurological outcome in diffuse axonal injury (DAI).
Methods and Materials: Seventy male patients 18-60 years with moderate to severe DAI admitted within the first 4 hours of injury were randomly divided into control and melatonin groups. The melatonin group received orally 3 mg melatonin at the time of admission, and it continued until the 15th day consecutive in addition to standard treatment. Glasgow coma scale (GCS) assessment was performed at the time of admission, fifteen days after injury and the day of discharge, while functional independence measure (FIM) and Glasgow coma scale (GOS) at the time of admission and the third and sixth months after injury.  
Results: There was significant difference in GCS between the control and melatonin groups at fifteen days post injury and GCS increased in the melatonin group (P<0.01). There was an increase in GOS and FIM scores in the melatonin group compared to the control group at three and six months after DAI (P<0.05). This score increased in the melatonin group at six months after injury compared to three months after injury (P<0.001). Unlike the control group, no death occurred in the melatonin group. 
Conclusion: The findings of this study showed the treatment of melatonin could probably improve neurological outcome in male patients with DAI. A study with larger sample size is needed to confirm the efficacy of melatonin in DAI. The mechanism of the effect of melatonin in DAI will be examined in a future study.
Keywords: Melatonin, Neurological Outcome, Diffuse Axonal Injury, Glasgow coma scale, Functional Independence Measure
Full-Text [PDF 253 kb]   (42 Downloads)    
Type of Study: Research | Subject: General
Received: 2024/02/21 | Accepted: 2023/08/10 | Published: 2023/08/10
Send email to the article author

Add your comments about this article
Your username or Email:

CAPTCHA


XML   Persian Abstract   Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Sabet N, Ghaed amini A, Karamouzian S, Khaksari M, Soltani Z. The Effect of Melatonin in Diffuse Axonal Injury: A Clinical Trial. Koomesh 2023; 25 (5) :12-12
URL: http://koomeshjournal.semums.ac.ir/article-1-8952-en.html


Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Volume 25, Issue 5 (Sep and Oct 2023 2023) Back to browse issues page
کومش Koomesh
Persian site map - English site map - Created in 0.05 seconds with 38 queries by YEKTAWEB 4645